1. The Importance of Achieving Additional Drug Benefits at a Reasonable Cost

   • Nick Freemantle
   • James Mason

   Current Opinion 15 October 2012 Pages: 319 - 324

2. Cost Effectiveness of Combination HIV Therapy

   • Richard D. Moore

   Current Opinion 15 October 2012 Pages: 325 - 330

3. Economic Burden of Irritable Bowel Syndrome

   • Michael Camilleri
   • Donald E. Williams

   Review Article 15 October 2012 Pages: 331 - 338

4. Inference for the Cost-Effectiveness Acceptability Curve and Cost-Effectiveness Ratio

   • Anthony O’Hagan
   • John W. Stevens
   • Jacques Montmartin

   Review Article 15 October 2012 Pages: 339 - 349

5. Potential Savings in the Cost of Caring for Alzheimer’s Disease

   • A. Brett Hauber
   • Ari Gnanasakthy
   • Josephine A. Mauskopf

   Original Research Article 15 October 2012 Pages: 351 - 360

6. Costs Incurred by Patients Undergoing Advanced Colorectal Cancer Therapy

   • Mark Sculpher
   • Michael K. Palmer
   • Anne Heyes

   Original Research Article 15 October 2012 Pages: 361 - 370

7. Initial Treatment Choice in Depression

   • Eric T. Edgell
   • Timothy R. Hylan
   • Stephen Joel Coons

   Original Research Article 15 October 2012 Pages: 371 - 382

8. Cost Analysis of the Treatment of Schizophrenia in the UK

   • Stephen Almond
   • Owen O’Donnell

   Original Research Article 15 October 2012 Pages: 383 - 389

9. Cost Effectiveness of Competing Strategies to Prevent or Treat GORD-Related Dysphagia

   • Amnon Sonnenberg

   Original Research Article 15 October 2012 Pages: 391 - 401